Aerie doses first patient in phase 3 DED treatment study
May 24, 2022
The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.
May 25, 2022
Investigators from the Sun Yay-Sen University in Guangzhou have created a theranostic device that targets sensing rising fluid pressures within the eye to automatically deliver medication for a glaucoma patient.
May 24, 2022
The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.
May 24, 2022
Maria Sampalis, OD, continues her dry eye discussion what factors she considers when diagnosing and treating patients.